Serotonin and bipolar disorder

Journal of Affective Disorders

Volumn 66, Issue 1, 2001, Pages 1-11

  Mahmood, Tariq ^a,b   Silverstone, Trevor ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

Author keywords

5 HT; Bipolar; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; FENFLURAMINE; FLUOXETINE; HALOPERIDOL; LITHIUM CARBONATE; LITHIUM SALT; OLANZAPINE; PAROXETINE; RADIOLIGAND; RISPERIDONE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; VALPROATE SEMISODIUM; VALPROIC ACID;

BIPOLAR DEPRESSION; CEREBROSPINAL FLUID; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHIZOIDISM; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE FUNCTION; VARIABLE NUMBER OF TANDEM REPEAT;

BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER; HUMANS; RECEPTORS, SEROTONIN;

EID: 0034862550     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00226-3     Document Type: Review

References (76)

1. Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium
2. CSF monoamine metabolites in melancholia
3. The neuroendocrine response to fenfluramine in depressive and normal controls
4. 3H imipramine binding in affective disorders: Trait versus state characteristics
5. Association between the tryptophan hydroxylase gene and manic-depressive illness
6. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness
7. A Danish twin study of manic-depressive disorders
8. A concept for the role of serotonin and norepinephrine as chemical mediators in the brain
9. Evidence for genetic inheritance of primary affective disorder in adoptees
10. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive-aggressive behaviour
11. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder
12. Segregation and linkage analysis in five manic depression pedigrees exclude the 5HT1a-receptor gene (HTR1A)
13. Serotonin function and the mechanism of antidepressant action
14. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
15. Platelet tritiated imipramine binding in patients suffering from mania
16. The human serotonin 7 (5-HT7) receptor gene: Genomic organization and systematic mutation screening in schizophrenia and bipolar disorder
17. A functional variant of the serotonin transporter gene in families with bipolar affective disorder
18. A double blind comparison of valproate and lithium in the treatment of acute mania
19. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders
20. Neuroleptics for bipolar maintenance
21. Family and genetic studies of affective disorders in the Eastern United States: A provisional summary
22. The neuroendocrine challenge paradigm in headache research
23. Allelic association analysis of the 5-HT2 receptor gene in bipolar affective-disorder
24. Serotonin transporter gene and risk for bipolar affective disorder: An association study in Spanish population
25. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study
26. Long-term valproate prophylaxis in refractory affective disorder
27. A review of functional neuroimaging in mood disorders: Positron emission tomography and depression
28. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates
29. Tritiated imipramine binding distinguishes among subtypes of depression
30. The induction of mania: A natural history study with controls
31. Hormonal responses to fenfluramine and placebo challenge in endogenous depression
32. Mania associated with olanzapine
33. The spectrum of behaviours influenced by serotonin
34. The serotonin hypothesis of major depression
35. Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: Evidence for increased central serotonergic neurotransmission
36. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment
37. Reanalysis and follow-up of a twin study of affective disorder using research diagnostic criteria
38. Prevalence of migraine in bipolar disorder
39. Serotonergic dysfunction in bipolar disorder
40. Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines
41. Changes in platelet 5-hydroxytryptamine uptake in mania
42. Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders
43. Morbidity risk and genetic transmission in manic depressive illness
44. Adoption study supporting genetic transmission in manic-depressive illness
45. Hormonal responses to fenfluramine in depressed and control subjects
46. Paradoxical effects of lithium on serotonergic receptor function: An immunocytochemical, behavioural and autoradiographic study
47. 3H-imipramine binding in bipolar patients
48. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: A critical review
49. Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients
50. Single-photon emission computed tomography of the brain in acute mania and schizophrenia
51. Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder
52. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants
53. Lithium treatment and serotonergic function
54. Serotonin function and depression: Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects
55. SSRI supplementation of antimanic medication in dysphoric mania
56. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: Hypothermic, hormonal, and behavioural responses to ipsapirone
57. Serotonin, a 'Sphynx' in migraine
58. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression
59. Mood, food and 5-HT
60. Blood platelets as a model for monoamine containing neurons
61. Reconciling the role of central serotonin neurons in human and animal behaviour
62. Modulatory role of serotonin in neural information processing: Implications for human psychopathology
63. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression
64. Risperidone induction of mania: Fact or fallacy
65. CSF monoamine metabolites in mania
66. D-Fenfluramine-induced prolactin responses in mania: Evidence for serotonergic subsensitivity
67. Monoamine metabolites in CSF and suicidal behaviour
68. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorder
69. Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain
70. Prolactin and cortisol responses to fenfluramine challenge in mania
71. Neuroendocrine probes of serotonergic function: A critical review
72. Sumatriptan-induced growth hormone release in patients with major depression, mania, and normal controls
73. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder
74. Is clozapine a mood stabilizer?